Lack of AVNRT Induction. Introduction: AV nodal reen(ran( tachycardia (AVNRT) is not aiways rcproducibiy inducible. The purpose of this study was to determine the mechanisms responsible for the lack of reproducible induction of AVNRT.
Introduction
Although AV nodal reentrant tachycardia (AVNRT) is usually inducible by atrial or ventricular pacing, sometimes it may not be reproducibly inducible or may require isoproterenol or atiopine administniiion for induction.'-No prior study has quanlitated the mechanisms responsi-ble for the nonreprtxlucible induction of this arrhythmia. Therefore, the purpose of this study was to detennine the mechanisin(s) responsible for lack of reproducible induction of AVNRT.
Methods

Patient Characteristics
The subjects of this study were 103 consecutive patients (24 male and 79 female; mean age 55 ± 7 years) with paroxysmal supraventricular tachycardia (PSVT) who underwent an electrophysiologic test and were found to have typical AVNRT. None of the patients had structural heart disease. The patients had been symptomatic from AVNRT for 16 ± 12 months.
Electrophysiologic Testing
Electrophysiologic tests were performed in the postabsorptive state after informed consent was obtained and after all antiarrhythmic medications had been discontinued for at least tive half-lives. Three 7-French quadripolar electrodes were inserted in a femoral vein and positioned in the high right atrium, across the tricuspid valve to record the His-bundle electrogram, and in the right ventricle. Leads V,. I, II. and III and the intracardiac electrograms were displayed on an oscilloscope and recorded on a Mingograf 7 recorder (SiemensElema, Solna. Sweden). Pacing was performed with a programmable simulator (Bloom Associates. Reading, PA. USA). The electrophysiologic test was directed at inducing and detennining the mechanism of PSVT, as well as mea-^uring the conduction properties and the refractory periods of the AV node.' If the PSVT could not be provoked in the baseline state, programmed stimulation was repeated during infusion of 2 /jg/min of isoproterenol. Incremental pacing and programmed simulation were performed from the right atrium and right ventricle to define anterograde and retrograde AV nodal conduction properties and refractoriness, and to confirm that the provoked arrhythmia was in fact AVNRT. Typical AVNRT was diagnosed using previously established criteria.Â
VNRT Induction Protocol
After the tachycardia was induced once and the diagnosis of typical AVNRT was continned, patients underwent the investigational protocol, which was approved by the University of Michigan Committee on Human Research. The stimulation protocol consisted of 18 steps (Table 1) . Patients only underwent the subsequent step of the induction protocol if the previous one did not achieve the endpoint of sustained AVNRT induction in at least 7 of 10 attempts. AVNRT that persisted for at least 30 seconds was defined as sustained. The first step of the stimulation protocol used incremental atrial pacing starting at 30 msec longer than the AV block cycle length. One attempt was defined as constant atriai pacing at 30 msec above the AV block cycle length, then 20 msec above tbe AV block cycle length, 10 msec above the AV block cycle length, at the AV block cycle length, and finally at 10 msec below the AV blcKk cycle Step No. length. During atrial pacing, the Sis were delivered until AH prolongation and subsequent AH block occurred or, if AH block did not occur, for at least 5 seconds. As with each step of the protocol, this was repeated 10 times. If the AVNRT induction endpoint was not reached, the second step of the protocol, programmed stitnulation of the atria (Al) with a single premature atrial extrastimulus {A2) was pertbrmed. A1A2 stitnulation was pertbrmed with eight S1 s and with at least two basic drive cycle lengths (6(X), 5{X), 400, 350 msec). The A1A2 coupling interval was decremented in 10-msec steps until AVNRT was induced or until the atrial or AV nodal refractory period was reached. The third step consisted of programmed atrial stimulation with two extrastimuli (A2A3). The third atrial extrastimulus was decre-merited in a manner similar to that described for A2. The AiA2 coupling interval was selected to be 10 to 30 msec longer than the fast pathway effective refractory period. The fourth step used fixed rate right ventricular pacing at 30. 20, and 10 msec above the VA block cycle length, at the VA block cycle length, and at 10 msec shorter than the VA block cycle length. One attempt wjis defined in a manner similar to that described above in step 1 for fixed rate atrial pacing.
Step 5 was programmed stimulation of the right ventricle with one extrastimulus, and step 6 was with two extrastimuli. When two ventricular extrasfimuli were used, the V1V2 coupling interval was the shortest coupling interval associated with VA conduction. When the endpoint of at least 7 of 10 successful inductions of AVNRT was not achieved in the baseline state witb steps 1 through 6, each step was repeated during the infusion of 2 /jg/min of intravenous isoproterenol infusion {steps 7 to 12). If the endpoint was not achieved during isoproterenol administiation. the infusion was di.scontinued. After at least 20 minutes, atropine (I mg) was injected, and pacing steps 13 to 18 were performed (Table I ).
In accord with the selection criteria for this study, all patients had AVNRT that could be provoked at least once, allowing the diagnosis to be established. However, in some patients, after the diagnosis of AVNRT was established, the arrhythmia could not be induced again despite performing steps I through 18.
Mechanisms of Noninduction of AVNRT
The general mechanisms responsible for noninducibility of a reentrant tachycardia include the inability to initiate reentry and the inability to maintain reentry. More specifically, when AVNRT could not be reproducibly provoked, I of 3 mechanisms for noninduction was identified. The first mechanism, an example of the inability to initiate reentry, was the inability to attain the critical atrialHis (AH) interval required for induction of AVNRT. This mechanism was determined to be responsible if the maximum AH during failed attempts to induce AVNRT was shorter than the shortest AH present when tachycardia was induced (Fig. 1) . The second possible mechanism was block in the fast pathway. When manifest as a prolonged VA block cycle length (> 350 msec), absent VA conduction,-* or critical AH prolongation without an AV nodal echo, this would be another example of failure to initiate reentry. When a few echoes occurred and termination was due to retrograde fast patbway block, this was an example of the inability to maintain reentry (Fig. 2) . The third possible mechanism was block in the slow pathway. An AV block cycle length > 400 msec would prevent tachycardia induction,^ while a retrograde AV nodal echo(s) with subsequent anterograde slow pathway block would prevent maintainanee of the tachycardia (Fig. 3) .
Statistical Analysis
Continuous variables are expressed as mean ± 1 SD and were compared using a /-test for paired or unpaired variables. Chi-square analysis was used to compare the frequencies of the mechanisms responsible for inability to AVNRT. P values < 0.05 were considered statistically significant.
Results
Inducibility
The endpoint of AVNRT induction in at least 7 of 10 attempts was achieved in 90 of the 103 patients (Fig. 4) . The number of AVNRT inductions in the remaining 13 patients ranged from 0 to 6 (Fig. 4) .
Mode of AVNRTInduction
Following the initial induction required to establish the diagnosis of the tachycardia, only steps 1, 2, 4, 7, 8, and 13 of the pacing protocol achieved tbe endpoint of inducible AVNRT in at least 7 of 10 attempts (Fig. 5) . This included 84 patients who were inducibie with tixed rate atrial pacing (steps 1, 7, and 13), 5 who were induced witb atrial programmed stimulation with a single atrial extrastimulus (steps 2 and 8), and 1 patient in whom burst ventrieular pacing (step 4) was effective. Atrial programmed stimulation with two atrial extrastimuli (steps 3, 9, and 15) and ventricular programmed stimulation with one and two extrastimuli (steps 5, 6, 11, 12, 17, and 18) did not result in achievement of the endpoint in any patient.
Drug State During A VNRT Induction
Among the 90 patients in whom AVNRT was induced in at least 7 of 10 attempts, after the initial induction required to establish the diagnosis of the tachycardia, 55 had the endpoint reached in the baseline state, 34 during isoproterenol infusion, and 1 after the administration of atropine. One patient who did not have inducible AVNRT in the baseline state or during isoproterenol infusion did not receive atropine because of a history of atropine intolerance. There was no difference in identifiable baseline clinical characteristics of patienus who attained the AVNRT induction endpoint in the baseline state versus during drug administration. However, tbere were several electrophysiologic characteristics that were different between patients who achieved the induction endpoint in the baseline state and those who did not ( Table 2 ). The electrophysiologic pitrameters of patients who required isoproterenol to achieve the induction endpoint are shown in Table 3 .
Mechanisms Responsible for Noninducihility of AVNRT
After the initial induction of AVNRT to establish the diagnosis, the endpoint of 7 or more AVNRT inductions out of 10 attempts was not acbieved in 48 patients in the baseline state (Table  4) . Among these 48 patients. 14 did not achieve the endpoint during isoproterenol administration and 12 did not achieve the endpoint after atropine administration. Therefore, there were a total of 74 inducfion attempts that did not attain the endpoint of at least seven inductions of AVNRT. The mechanisms responsible for not achieving the endpoint were tbe inability to attain a critical AH interval in 22 patients (30%), failure of conduc-500 msec B 500 msec 
msec). Despite the jump, the tachycardia is not induced due to retrograde fast pathway block-
Figure 2. (Continued) (C) Critical prolongation of the AH interval i.s demonstrated. With fixed rate atrial pacing at 250 msec, critical AH prolongation occurs (230 msec), the retrograde fast pathway is no longer refractory, ami the tachycardia is initiated. The tracings and abbreviations are as described in Figure J, except lead II is also shown.
tion in the fast pathway in 27 patients (36%), and failure of slow pathway conduction in the remaining 25 patients (34%). There was one patient in whom two mechanisms were identified as the etiology of noninduction in the baseline .state. Both of these mechanisms were included in the analysis. In the baseline state, there were 48 patients in whom AVNRT was inducible in < 7 of 10 attempts. The inability to achieve a critical AH interval was the mechanism responsible in 20%, fast pathway conduction block was responsible in 49%, and slow pathway block was the mechanism responsible in 31% of the patients (P = 0.02). The same mechanism was responsible Ior noninduction in each step of the protocol, except in one patient in whom the lack of induction during step 1 was due to the inability to achieve a critical AH interval, while the mechanism in the remaining steps during the baseline state was slow pathway bkxrk. There was only one patient in whom step 4 (fixed rate ventricuhir pacing) resulted in achievement of the endpoint. In this patient, during atrial pacing (steps I through 3). AVNRT induction was limited by retrograde fast pathway block.
During isoproterenol admini.stration, only 14 of the 48 patients (29%) in whom the induction endpoint was not reached in the baseline state had tachycardia that could not he reliably provoked. In these 14 patients, the endpoint was not attained because of inability to achieve critical AH lengthening in 6 patients (43%), fast pathway conduction block in 2 patients (14%), and slow pathway conduction block in 6 patients (43%; P = NS).
Ajnong 13 patients in whom the endpoint was not achieved in the baseline slate or during isoproterenol infusion, atropine administration resulted in achievement of the induction endpoint in only one patient. After atropine administration, inability to adequately lengthen the AH interval, fast pathway block, and slow pathway block were the mechanisms responsihle for lack of AVNRT induction in 6 patients (50%), 5 patients (42%), and 1 patient (8%; P = NS), respectively.
The mechanism responsible for lack of AVNRT induction was the same with each step of the protocol for a particular dmg state. However, the nnechanism at times differed with the administration of different drugs. For instance, in the 12 patients in whom the tachycardia could never be induced at least seven times, the mechanism resptmsible was the same in each drug state in 6 patients: the inability to achieve a critical AH interval in 3 patients, consistent fast pathway block in 1 patient, and consistent slow pathway block in 2 patients were the mechanisms responsible in each dmg state and during each step oi' ihe protocol. In the remaining 6 patients, fast pathway block was responsible in the baseline state in each patient, hut in only I during i.soproterenol administration. The isoproterenol had improved fast pathway conduction in the others, but slow pathway conduction bkxrk occurred in 2, and inadequate AH prolongation prevented reproducible AVNRT induction in 3. After atropine, slow pathway failure (n = 3) and lack of adequate AH prolongation (n = 3) were responsible for the inability to induce AVNRT in at least 7 of 10 attempts.
Four of the 103 patients in this study were diagnased with AVNRT, but the arrhythmia was never provocable again. The mechanism responsible for no further inductions of AVNRT in these 4 patients was consistent slow pathway conduction failure in 2 patients and consistent inadequate AH prolongation in 1 patient. In the remaining patient, fast pathway conduction block limited induction in the baseline state, but after isoproterenol and atropine administration, inadequate AH prolongation prevented tachycardia induction.
ITiere were also eight patients in whom the endpoint was met, but the tachycaidia was not induced 10 times. Seven of these 8 patients met the induction endpoint in the baseline state, and one patient achieved the endpoint during isoproterenol infusion. The mechanism responsible for < 10 inductions was lack of critical AH prolongation in 2 patients and slow pathway conduction bk>ck in 5 patients. In the last patient, fast pathway conduction block limited induction in the baseline state and prevented 10 inductions during isoproterenol infusion.
Discussion
Main Findings
These results demonstrate that after the diagnosis of AVNRT is established, AVNRT can be in- Table 1 .
duced in at !ea.st 7 of 10 attempts in approximately 90% of patients with proven AVNRT if a variety of pacing and drug interventions are utilized. Fast pathway conduction failure is most commonly responsible for inability to achieve the induction endpoint in the baseline state, but with enhanced adrenergic tone, is rarely the weak link. Approximately 99% of patients who meet this induction endpoint will do so in the baseline state or after isoproterenol infusion. Atropine administration is rarely helpful when isoproterenol has not been helpful. Likewise, atrial pacing is the effective induction mode in over 90% of patients.
Autonomic Factors Affecting Noninducibility
The mechanism responsible for inability to achieve the endpoint of 7 inductions of AVNRT Table 2 .
out of 10 attempts in the baseline state was most frequently fast pathway block. This implies that the fast pathway is frequently the weak link for induction in the baseline slate, but fast pathway block is rarely responsible for inability to achieve the induction endpoint during autonomic stimulation. This observation suggests that fast pathway conduction is more marginal in the absence of sympathetic stimulation than is slow pathway conduction. Inability to achieve adequate AH lengthening may be easier to overcome with beta-blocker iherapy than with autonomic stimulation.^ Additionally, isoproterenol infusion could render the tachycardia more difficult to induce, especially if the fast pathway refractory period were to become shorter than the slow pathway refractory period.
A previous study demonstrated that in the absence of isoproterenol. the ventricular response during atrial fibrillation slows after slow pathway ablation for AVNRT/' However, recent observations demonstrate that the ventricular response increases when adrenergic tone is enhanced with isoproterenol.^ This phenomenom may also be due to the responsiveness of the fast pathway to adrenergic stimulation. No T AH = inability to achieve criliciil AH prolongation; FP = fast pathway; SP = slow pathway; NS = no statistical difference.
Previous Studies
In the present study, after isoproterenol administration, the induction endpoint wa.s still not achieved in approximately one third of patients, despite significantly improving anterograde and retrograde conduction-Isoproterenol has previously been shown to be beneficial for the induction of AVNRT in patients with dual AV nodal physiology, with iind without sustained reentry.' However, a halance of anterograde slow pathway and retrograde fast pathway conduction is required for tachycardia induction.'' Atropine was rarely helpful in inducing sustained AVNRT for patients in whom isoproterenol administiation did not cause reproducible AVNRT induction. Atropine consistently improved AV and VA conduction, yet this was not adequate to reprcxlucibly induce AVNRT. The results of a previous study suggested that atropine can be helpful at inducing AVNRT.-Because atropine improves anterograde and retrograde conduction., it is not surprising that atropine may aid in the induction of AVNRT-In the present study, i.soprotet^nol administration and atropine administration had similar effects on AV and VA conduction. Perhaps this is why atropine was rarely helpful in achieving the induction endpoint after isoprotereno! had been ineffective.
Limitations
The design of this study required that AVNRT be inducible at least once for the patient to be included in the study. There may be some patients with AVNRT who are completely noninducihle, and so these data may underestimate the true frequency of nonreproducible induction of AVNRT. An additional limitation of this study is that only a single do.se of isoproterenol and atropine were used. The results of this study may have been different if other doses were used.
Clinical Implications
Some patients with documented PSVT are completely noninducible, suggesting that their tachycardia may be automatic atrial tachycardia. However, the results of the present study suggest that the diagnosis of AVNRT is still possible and should be entertained when dual AV nodaJ physiology, with or without echties, is present. In this instance, if prior medical therapy has heen ineffective, empiric slow pathway ablation may be a reasonable therapeutic option. Additionally, the lack of reproducibly inducible AVNRT may lead to recurrences of AVNRT after an apparently successful ablation procedure, because lack of tachycardia induction may be mistaken for a successful procedure. Finally. AVNRT is often inducible with isoproterenol but not in the baseline state. The.se data imply that isoproterenol administration in conjunction with programmed stimulation of the atria and ventricles should be utilized to completely document the lack of inducible AVNRT after slow pathway ablation.**
